Viewing Study NCT00451035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2026-01-11 @ 8:38 PM
Study NCT ID: NCT00451035
Status: TERMINATED
Last Update Posted: 2021-07-15
First Post: 2007-03-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia in Chronic Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory Chronic Myeloid Leukemia in Chronic Phase View
None adults View
None oral LBH589 View